Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)
Clinical trial NCT05572970 · AVAILABLE
Trial details
- NCT number
- NCT05572970
- Sponsor
- Agenus Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.